PRESS RELEASE published on 08/04/2026 at 07:00, 1 month 22 days ago Press Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease Sanofi's MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease. Expanded indication for broad protection. Key milestone in public health EU Sanofi Infants MenQuadfi Meningococcal Disease
PRESS RELEASE published on 08/04/2026 at 07:00, 1 month 22 days ago Communiqué de presse : MenQuadfi de Sanofi approuvé dans l’UE pour une utilisation chez les nourrissons dès l’âge de six semaines contre les infections invasives à méningocoques Sanofi obtient l'approbation de MenQuadfi pour les nourrissons de six semaines pour lutter contre les infections invasives à méningocoques en Union européenne Sanofi Nourrissons MenQuadfi Infections Invasives Méningocoques
BRIEF published on 07/30/2026 at 15:43, 1 month 26 days ago Sanofi publie son rapport financier semestriel pour 2026 AMF Rapport Financier Sanofi SECONDE 2026
BRIEF published on 07/30/2026 at 15:43, 1 month 26 days ago Sanofi Releases Half-Year Financial Report for 2026 AMF Financial Report SEC Sanofi 2026
PRESS RELEASE published on 07/30/2026 at 15:38, 1 month 26 days ago Communiqué de presse : Rapport financier semestriel 2026 de Sanofi Sanofi annonce la publication de son rapport financier semestriel 2026. Consultez-le sur www.sanofi.com. Sanofi, entreprise biopharmaceutique innovante en R&D et IA Croissance R&D Biopharmaceutique Rapport Financier Sanofi
PRESS RELEASE published on 07/30/2026 at 15:38, 1 month 26 days ago Press Release: Sanofi’s half-year financial report for 2026 Sanofi announces availability of its half-year financial report for 2026, now accessible on www.sanofi.com, filed with AMF and submitted to SEC Investors Financial Report Sanofi Half-year 2026
BRIEF published on 07/10/2026 at 18:35, 2 months 15 days ago Sanofi : Mise à jour sur les droits de vote et actions en juin 2026 Droits De Vote Actions Investisseurs Sanofi Juin 2026
BRIEF published on 07/10/2026 at 18:35, 2 months 15 days ago Sanofi: Update on voting rights and shares in June 2026 Voting Rights Investors Actions Sanofi June 2026
BRIEF published on 07/10/2026 at 18:35, 2 months 15 days ago Sanofi Reports Share and Voting Rights Information for June 2026 Voting Rights French Commercial Code Issued Shares Financial Regulations Sanofi
BRIEF published on 07/10/2026 at 18:35, 2 months 15 days ago Sanofi publie des informations sur ses actions et ses droits de vote pour juin 2026 Réglementation Financière Droit De Vote Sanofi Code De Commerce Français Actions Émises
Published on 09/26/2026 at 01:00, 11 hours 38 minutes ago Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 11 hours 38 minutes ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 14 hours 23 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 19 hours 8 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 21 hours 38 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 07:45, 4 hours 53 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 12 hours 36 minutes ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 18 hours 8 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 18 hours 38 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:45, 18 hours 53 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 18 hours 58 minutes ago Availability of the 2026 half-year financial report